A5084300412- Hematopoietic Stem Cell Transplantation
- Neutropenia and Cancer Infections
- Blood groups and transfusion
- Infectious Diseases and Tuberculosis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Multiple Myeloma Research and Treatments
- Advanced MRI Techniques and Applications
- Tuberculosis Research and Epidemiology
- Mast cells and histamine
- Platelet Disorders and Treatments
- Cardiomyopathy and Myosin Studies
- Mycobacterium research and diagnosis
- Oral health in cancer treatment
- DNA and Biological Computing
- Genital Health and Disease
- Aortic Disease and Treatment Approaches
- Acute Myeloid Leukemia Research
- Cancer Treatment and Pharmacology
- Urticaria and Related Conditions
- Biosimilars and Bioanalytical Methods
- Cutaneous lymphoproliferative disorders research
- Cardiovascular Issues in Pregnancy
- Cardiac pacing and defibrillation studies
Instituto de Investigación Marqués de Valdecilla
2015-2023
Marqués de Valdecilla University Hospital
2015-2022
Vall d'Hebron Hospital Universitari
2017
Universidad de Cantabria
2011
Hippocampal remapping, in which place cells form distinct activity maps across different environments, is a robustly-observed phenomenon with many theories and interpretations. Some view remapping as the mechanism behind reduced interference between competing spatial memories, whereas others associate it changes an underlying latent state representation. However, remains unclear how these interpretations of relate to one another, what types they are compatible with. To shed some light on...
Abstract Although case-control analyses have suggested an additive value with the association of clarithromycin to continuous lenalidomide and dexamethasone (Rd), there are not phase III trials confirming these results. In this trial, 286 patients MM ineligible for ASCT received Rd or without until disease progression unacceptable toxicity. The primary endpoint was progression-free survival (PFS). With a median follow-up 19 months (range, 0–54), no significant differences in PFS were...
The Hospital at Home (HaH) model has been positioned as an appropriate therapeutic strategy for selected patients undergoing autologous hematopoietic stem cell transplantation (ASCT). This care provides hospital-equivalent care, in terms of both quality and quantity, with medical nursing staff that go to the patient's home. Here we describe our experience a full HaH ASCT during phase aplasia. met eligibility criteria between January 1997 December 2019 were discharged from hospital admitted...
Mycobacterium tuberculosis infections are uncommon complications in the haematopoietic stem cell post-transplant period. Most cases reactivations of latent affecting lung. We present an atypical case isolated lymph node after allogeneic transplantation, which highlights importance having a high suspicion index, even non-endemic countries.
Follicular lymphoma does not usually present with associated paraneoplastic syndromes.We describe the case of a patient diagnosed follicular when investigating anaemia chronic disease/inflammation and who, during her clinical course, developed peliosis hepatis.We have been able to confirm similarity between symptoms, tumour's biology, peliosis, behaviour endothelial growth factor, interleukins iron metabolism disorders, which were normalised treatment.To date, we found no cases where has...
A 77-year-old Caucasian woman presented to our hospital with difficulty swallowing solid food and weight loss during the past 2 years. She did not drink alcohol or smoke. Her physical examination her medical history were unremarkable. Radiograph of chest showed a right-sided aortic arch (Figure 1). Figure 1. Radiograph showing right (arrow). A …
Acquired amegakaryocytic thrombocytopenia is an unusual hematological disorder characterized by severe in association with a marked decrease, or the absence, of megakaryocytes bone marrow. Its pathogenesis not well understood and its clinical course variable. Several treatments have been used, producing different responses. We present case that was successfully treated calcineurin inhibitor combined thrombopoiesis-stimulating agent.
Introduction: Identifying patients at risk for sudden cardiac death (SCD) remains a challenge